Turnstone Biologics Corp. (TSBX) Net earnings per share growth forecast for next year
Turnstone Biologics (TSBX) growth is underpinned by a closed TIL-therapy ecosystem with exclusive patents. The expected EPS growth rate for the coming year confirms this potential, where the 0.00 metric determines the parameter status. Development is driven by massive R&D expenditures that create a barrier to entry for competitors, as well as strictly calibrated biocomponent logistics from certified suppliers.
Metric breakdowns and analytics for Turnstone Biologics (TSBX)
- price and consensus price forecast:
- market capitalization details:
- company book value details:
- company liabilities and liquidity data:
Debt to Equity Turnstone Biologics|TSBX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Turnstone Biologics|TSBX - Company Total Indebtedness|Debt to Book Value Turnstone Biologics|TSBX - Amount of Long-Term Liabilities|Company Short-Term Debts Turnstone Biologics|Quick Ratio turnstonebio.com
- earnings and market ratios statistics:
TSBX - Company Net Income|Expected Profit Turnstone Biologics|TSBX - Company Value to Net Income|Forward P/E Multiple Turnstone Biologics Corporation|TSBX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Turnstone Biologics Corp.|TSBX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Turnstone Biologics|TSBX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months turnstonebio.com|TSBX - Net earnings per one share growth for the current year|Expected earnings per share growth for next year Turnstone Biologics
- revenue and sales proceeds data:
Analysis of all company metrics:Turnstone Biologics
The asset quality assessment is based on the consensus earnings per share (EPS) forecast, which measures expected business efficiency through the lens of future cash flows. This growth benchmark for next year's net income per share reflects market confidence in the commercialization of complex R&D projects at Turnstone Biologics (TSBX), where the high scientific intensity of cell therapy creates a defensive barrier against competitors.
Direct competitors
Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|LPTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year INTS|Net earnings per share growth forecast for next year Sensei Biotherapeutics, Inc.|Expected net earnings per share growth next year therivabio.com TOVX|Expected earnings per share growth for next year GRTS (Gritstone bio, Inc.)|Earnings growth forecast for next year Kineta Bio (KA)|Net earnings per share growth forecast for next year NexImmune Corporation NEXI|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year
